ArticleClinical and translational medicine2025

Programmed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study.

Francesca Basso-Valentina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.